Add BrightSurf on Google Email

Effects of pediatric brain tumors and their treatment haunt survivors for years, study finds

A recent study published in the Journal of Clinical Oncology found that pediatric brain tumor survivors experience significant long-term effects from radiation and treatment. The study, led by Paul Fisher, MD, surveyed 134 former patients and discovered that those who received radiation had a poorer quality of life than those who only ...

SourceStanford Medicine·JournalJournal of Clinical Oncology·DateAug 18, 2005

New imaging method gives early indication if brain cancer therapy is effective, U-M study shows

Researchers developed a functional diffusion map using MRI scans to track water diffusion in the brain, finding that changes predicted tumor response 10 weeks before traditional techniques. This method could spare patients from ineffective treatment and allow doctors to switch to more effective therapies.

SourceMichigan Medicine - University of Michigan·JournalProceedings of the National Academy of Sciences·DateMar 28, 2005

Brain tumor with dismal prognosis in infants can be cured in older children

St. Jude Children's Research Hospital finds that upfront treatment with radiation followed by chemotherapy can cure brain tumors in children over 3 years old, raising survival rates to 78% for two-year event-free survival and 89% for overall survival. The study shows promise for treating relapse cases using ICE chemotherapy.

SourceSt. Jude Children's Research Hospital·JournalJournal of Clinical Oncology·DateMar 2, 2005

Treatment for brain tumor does not always follow recommendations

The study found significant variations in treatment practices for patients with malignant glioma, including differences in the use of radiation therapy, chemotherapy, and antidepressants. These variations were associated with differences in survival rates, highlighting the need for further investigation and potential improvements to tr...

SourceJAMA Network·JournalJAMA·DateFeb 1, 2005

Timing is everything for optimum combined cancer therapy

A new study published in Cancer Cell reveals that combining radiation with antiangiogenic therapy can significantly slow tumor growth when administered at the right time. The research found that a unique time period exists during which this combination is most effective, making it a potential breakthrough in cancer treatment.

SourceCell Press·JournalCancer Cell·DateDec 20, 2004

Promise of stem cells amplified

Scientists have successfully used stem cells to restore movement in paralyzed rats by transplanting oligodendrocytes, a type of cell that insulates nerve signals. Additionally, researchers have delivered GDNF, a factor aiding neuron survival, to patients with Parkinson's and Huntington's diseases using genetically modified astrocytes.

Lab study defines and blocks mechanism that lets brain tumors sidetrack immune response

Researchers at Cedars-Sinai Medical Center have discovered a mechanism by which brain tumors can evade the immune system, leading to impaired cellular immunity in patients with glioma. By blocking COX-2 expression, the study found that tumor-killing T cell responses can be restored, offering new potential treatments for brain tumors.

SourceCedars-Sinai Medical Center·JournalThe Journal of Immunology·DateOct 22, 2004

3-D irradiation of brain cancer in children spares IQ, memory, other cognitive functions

A study published in the Journal of Clinical Oncology found that 3D radiation therapy can effectively treat brain cancer in children without impairing cognitive development. The research suggests that radiation therapy can be a viable treatment option for young children, offering hope to families affected by this type of cancer.

SourceSt. Jude Children's Research Hospital·JournalJournal of Clinical Oncology·DateAug 5, 2004

New technology blocks gene to increase immune response against deadly brain tumor cells

Researchers at Cedars-Sinai Medical Center have developed a new approach to boost the immune response against gliomas, a type of brain tumor. By targeting the interleukin 10 gene in dendritic cells, they can increase the production of IL-12, leading to a stronger Th1 response and enhanced immune response against cancer cells.

SourceCedars-Sinai Medical Center·JournalEuropean Journal of Immunology·DateMay 24, 2004

Crucial brain development gene identified

Researchers have identified a critical gene called Lgl1, which plays a vital role in shaping cell behavior during embryonic brain development. The study found that mice lacking this gene exhibit dramatic abnormalities and resemble human patients with medulloblastoma, a type of brain tumor.

SourceCold Spring Harbor Laboratory·JournalGenes & Development·DateMar 9, 2004